Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S. (KE), M.R.C.P (UK), M.D. (KE Medalist)
Internal Medicine Specialist
M.B.B.S. (KE), M.R.C.P (UK), M.D. (KE Medalist)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Rheumatologist
M.B.B.S., F.C.P.S., SCE Rheumatology
Gastroenterologist
MBBS, FMGEMS, FLEX, F.A.C.P, Diplomate of the American Board of Internal Medicine, Diplomate of the American Board of Gastroenterology
Gastroenterologist
MBBS, FMGEMS, FLEX, F.A.C.P, Diplomate of the American Board of Internal Medicine, Diplomate of the American Board of Gastroenterology
Consultant Physician
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Endocrinologist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S. (Endocrinologist)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Consultant Physician
M.B.B.S, F.C.P.S, F.P.S.I.M, C.H.P.E, M.A.C.G
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures